Related Experiment Videos

A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine

R Sakai1, A Iwamatsu, N Hirano

  • 1Molecular Biology Division, Jichi Medical School, Tochigi, Japan.

The EMBO Journal
|August 15, 1994
PubMed

Insights

v-Crk and v-Src oncoproteins phosphorylate p130, a novel signaling molecule. This protein, now named p130Cas, acts as a common cellular target, potentially assembling signals from multiple SH2-containing molecules.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncogenesis

Background:

  • v-Crk is a transforming protein that elevates tyrosine phosphorylation.
  • p130 is a cellular protein strongly associated with and phosphorylated by v-Crk.

Purpose of the Study:

  • To identify and characterize the p130 protein.
  • To understand the role of p130 in signaling pathways involving v-Crk and v-Src.

Main Methods:

  • Immunoaffinity purification to isolate rat p130.
  • Immunochemical analyses and peptidase mapping.
  • Subcellular fractionation.

Main Results:

  • p130 was cloned and identified as a novel SH3-containing signaling molecule with SH2-binding motifs.
  • p130 is highly tyrosine phosphorylated and forms complexes with v-Crk and v-Src oncoproteins.
  • p130 acts as a potent substrate for Src kinase and translocates to the membrane upon phosphorylation.

Conclusions:

  • p130 (p130Cas) is a common cellular target for v-Crk and v-Src signaling.
  • Its structure suggests a role in signal assembly from SH2-containing molecules.

Related Concept Videos